↓ Skip to main content

Cannabinoid type 1 receptor antagonists for smoking cessation

Overview of attention for article published in Cochrane database of systematic reviews, March 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
262 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoid type 1 receptor antagonists for smoking cessation
Published in
Cochrane database of systematic reviews, March 2011
DOI 10.1002/14651858.cd005353.pub4
Pubmed ID
Authors

Kate Cahill, Michael H Ussher

Abstract

Selective type 1 cannabinoid (CB1) receptor antagonists may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. They also seeks to address many smokers' reluctance to persist with a quit attempt because of concerns about weight gain.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 262 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Brazil 1 <1%
Unknown 259 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 42 16%
Researcher 36 14%
Student > Bachelor 26 10%
Student > Ph. D. Student 23 9%
Student > Doctoral Student 13 5%
Other 43 16%
Unknown 79 30%
Readers by discipline Count As %
Medicine and Dentistry 62 24%
Nursing and Health Professions 23 9%
Psychology 23 9%
Social Sciences 13 5%
Pharmacology, Toxicology and Pharmaceutical Science 11 4%
Other 40 15%
Unknown 90 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2022.
All research outputs
#7,993,771
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#8,729
of 11,499 outputs
Outputs of similar age
#41,179
of 119,410 outputs
Outputs of similar age from Cochrane database of systematic reviews
#65
of 97 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,410 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.